Vera Therapeutics Inc [VERA] stock is trading at $45.03, up 0.29%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VERA shares have gain 36.45% over the last week, with a monthly amount glided 78.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vera Therapeutics Inc [NASDAQ: VERA] stock has seen the most recent analyst activity on October 16, 2025, when BofA Securities initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research downgraded its rating to Peer Perform on August 04, 2025. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $49 on February 04, 2025. Goldman initiated its recommendation with a Buy and recommended $58 as its price target on January 28, 2025. Wells Fargo started tracking with a Overweight rating for this stock on November 21, 2024, and assigned it a price target of $70. In a note dated October 16, 2024, Scotiabank initiated an Sector Outperform rating.
Vera Therapeutics Inc [VERA] stock has fluctuated between $18.53 and $49.77 over the past year. Currently, Wall Street analysts expect the stock to reach $86.67 within the next 12 months. Vera Therapeutics Inc [NASDAQ: VERA] shares were valued at $45.03 at the most recent close of the market. An investor can expect a potential return of 92.47% based on the average VERA price forecast.
Analyzing the VERA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.47 and Total Capital is -0.43. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 43.32 points at the first support level, and at 41.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.92, and for the 2nd resistance point, it is at 48.81.
Ratios To Look Out For
For context, Vera Therapeutics Inc’s Current Ratio is 12.09. Also, the Quick Ratio is 12.09, while the Cash Ratio stands at 1.46.
Transactions by insiders
Recent insider trading involved WILLIAM TURNER, Officer, that happened on Dec 08 ’25 when 10000.0 shares were purchased. Chief Regulatory Officer, Turner William D. completed a deal on Dec 03 ’25 to sell 10000.0 shares. Meanwhile, Officer WILLIAM TURNER bought 10000.0 shares on Dec 03 ’25.
